In summary, we have shown that the increased sensitivity of Nlrp3−/− mice to DSS-induced colitis can be normalized by neutralizing IL-15, an effect that decreases the number of mucosal foxp3+ T cells and significantly reduces the colonic expression of IL-12p40 and IL-17. This evidence concerns the gene NLRP3 and colitis.